3.0
24 Apr 2015
Current employee, more than 8 years
Moscow, Moskva
Recommend
CEO approval
Business outlook
Pros
Innovative company, looking for acquisitions, significant investments in emerging markets, many launches of new products, one of them potential blockbuster in oncology that is breakthrough therapy
Cons
Transformation 3 years in a row, many people left the company, internal initiative on talents doesn't work, prefer hiring outside, competition is not competitive